Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 47 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 8668863

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted

  2. US 8663649

    Diagnosis and treatment of Trypanosoma cruzi infection and Chagas disease

    The Board of Regents of the University of Texas System · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  3. US 8658664

    Cyclopamine tartrate salt and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  4. US 8658168

    Compositions and methods for homoconjugates of antibodies which induce growth arrest of apoptosis of tumor cells

    The Board of Regents of the University of Texas System · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  5. US 8658778

    hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes

    The Board of Regents of the University of Texas System · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  6. US 8653243

    Pertussis antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  7. US 8653034

    Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives

    The Board of Regents of the University of Texas System · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  8. US 8652366

    Aerosol-mediated particle synthesis

    The Board of Regents of the University of Texas System · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  9. US 8648102

    Compounds for treatment of cell proliferative diseases

    The Board of Regents of the University of Texas System · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  10. US 8637675

    Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS)

    The Board of Regents of the University of Texas System · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  11. US 8637503

    Phenothiazine enantiomers as agents for the prevention of bone loss

    The Board of Regents of the University of Texas System · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  12. US 8632510

    Nanochanneled device and related methods

    The Board of Regents of the University of Texas System · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  13. US 8629119

    Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders

    The Board of Regents of the University of Texas System · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  14. US 8617538

    Mesodermal-like cell population for treating ischemia in mammals

    The Board of Regents of the University of Texas System · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  15. US 8618074

    GPCR enhanced neuroprotection to treat brain injury

    The Board of Regents of the University of Texas System · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  16. US 8618167

    Methods of attenuating cognitive deficits with sulfonyl fluorides

    The Board of Regents of the University of Texas System · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  17. US 8618324

    Composition and method for making oligo-benzamide compounds

    The Board of Regents of the University of Texas System · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  18. US 8614082

    Attenuation of encephalitogenic alphavirus and uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  19. US 8613944

    Compositions and methods for separating tissue

    The Board of Regents of the University of Texas System · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  20. US 8609067

    Method of measuring propulsion in lymphatic structures

    The Board of Regents of the University of Texas System · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  21. US 8604074

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  22. US 8597616

    Dry powder drug delivery formulations, methods of use, and devices therefore

    The Board of Regents of the University of Texas System · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  23. US 8592384

    Micro-RNA's that regulate muscle cells

    The Board of Regents of the University of Texas System · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  24. US 8586046

    Methods and compositions for mycoplasma pneumoniae exotoxins

    The Board of Regents of the University of Texas System · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.